A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America

Clinical trial NCT01297504 · COMPLETED

Trial details

NCT number: NCT01297504
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Study type: OBSERVATIONAL

Respiratory Syncytial Virus Infection

Start date: 2011-02-01
Primary completion: 2013-08-01
Enrollment: 464

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.